Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-20T03:59:44.878Z Has data issue: false hasContentIssue false

Excess Length of Stay Due to Central Line–Associated Bloodstream Infection in Intensive Care Units in Argentina, Brazil, and Mexico

Published online by Cambridge University Press:  02 January 2015

Adrian G. Barnett*
Affiliation:
Institute of Health and Biomedical Innovation and School of Public Health, Queensland University of Technology, Kelvin Grove, Australia
Nicholas Graves
Affiliation:
Institute of Health and Biomedical Innovation and School of Public Health, Queensland University of Technology, Kelvin Grove, Australia
Victor D. Rosenthal
Affiliation:
International Nosocomial Infection Control Consortium, Buenos Aires, Argentina
Reinaldo Salomao
Affiliation:
Santa Marcelina Hospital, Sao Paulo, Brazil
Manuel Sigfrido Rangel-Frausto
Affiliation:
Specialties IMSS Hospital, Mexico City, Mexico
*
Institute of Health and Biomedical Innovation and School of Public Health, 60 Musk Avenue, Queensland University of Technology, Kelvin Grove, Australia, (a.barnett@qut.edu.au)

Extract

Objective.

To estimate the excess length of stay in an intensive care unit (ICU) due to a central line-associated bloodstream infection (CLABSI), using a multistate model that accounts for the timing of infection.

Design.

A cohort of 3,560 patients followed up for 36,806 days in ICUs.

Setting.

Eleven ICUs in 3 Latin American countries: Argentina, Brazil, and Mexico.

Patients.

All patients admitted to the ICU during a defined time period with a central line in place for more than 24 hours.

Results.

The average excess length of stay due to a CLABSI increased in 10 of 11 ICUs and varied from -1.23 days to 4.69 days. A reduction in length of stay in Mexico was probably caused by an increased risk of death due to CLABSI, leading to shorter times to death. Adjusting for patient age and Average Severity of Illness Score tended to increase the estimated excess length of stays due to CLABSI.

Conclusions.

CLABSIs are associated with an excess length of ICU stay. The average excess length of stay varies between ICUs, most likely because of the case-mix of admissions and differences in the ways that hospitals deal with infections.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Crnich, CJ, Maki, DG. The role of intravascular devices in sepsis. Curr Infect Dis Rep 2001;3(6):496506.Google Scholar
2.Rosenthal, VD, Guzman, S, Orellano, PW. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 2003;31(5):291295.CrossRefGoogle ScholarPubMed
3.Rosenthal, VD, Guzman, S, Crnich, C. Device-associated nosocomial infection rates in intensive care units of Argentina. Infect Control Hosp Epidemiol 2004;25(3):251255.Google Scholar
4.Rosenthal, VD, Maki, DG, Salomao, R, et al.Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006;145(8):582591.Google Scholar
5.Moreno, CA, Rosenthal, VD, Olarte, N, et al.Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol 2006;27(4):349356.CrossRefGoogle ScholarPubMed
6.Ramirez Barba, EJ, Rosenthal, VD, Higuera, F, et al.Device-associated nosocomial infection rates in intensive care units in four Mexican public hospitals. Am J Infect Control 2006;34(4):244247.CrossRefGoogle ScholarPubMed
7.Mehta, A, Rosenthal, VD, Mehta, Y, et al.Device-associated nosocomial infection rates in intensive care units of seven Indian cities: findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007;67(2):168174.CrossRefGoogle ScholarPubMed
8.Leblebicioglu, H, Rosenthal, VD, Arikan, OA, et al.Device-associated hospital-acquired infection rates in Turkish intensive care units: findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007;65(3):251257.Google Scholar
9.Salomao, R, Rosenthal, VD, Grimberg, G, et al.Device-associated infection rates in intensive care units of Brazilian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica 2008;24(3):195202.Google Scholar
10.Cuellar, LE, Fernandez-Maldonado, E, Rosenthal, VD, et al.Device-associated infection rates and mortality in intensive care units of Peruvian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica 2008;24(1):1624.Google Scholar
11.Rosenthal, VD, Maki, DG, Mehta, A, et al.International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control 2008;36(9):627637.CrossRefGoogle ScholarPubMed
12.Rosenthal, VD. Central line-associated bloodstream infections in limited-resource countries: a review of the literature. Clin Infect Dis 2009;49(12) :18991907.Google Scholar
13.Madani, N, Rosenthal, VD, Dendane, T, Abidi, K, Zeggwagh, AA, Abouqal, R. Healthcare-associated infections rates, length of stay, and bacterial resistance in an intensive care unit of Morocco: findings of the International Nosocomial Infection Control Consortium (INICC). Int Arch Med 2009;2(1):29.CrossRefGoogle Scholar
14.Beyersmann, J, Gastmeier, P, Grundmann, H, et al.Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 2006;27(5):493499.Google Scholar
15.Stone, PW, Gupta, A, Loughrey, M, et al.Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003;24(8):601606.CrossRefGoogle Scholar
16.Graves, N, Hakton, K, Robertus, L. Chapter 17: costs of healthcare associated infection. In: Ferguson, J, Cruikshank, M, eds. National Surveillance of Health Care Associated Infection in Australia. Canberra: Australian Commission on Safety and Quality in Health Care (ACSQHC), 2008.Google Scholar
17.Rosenthal, VD, Guzman, S, Migone, O, Crnich, CJ. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control 2003;31(8):475480.Google Scholar
18.Higuera, F, Rangel-Frausto, MS, Rosenthal, VD, et al.Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol 2007;28(1):3135.CrossRefGoogle ScholarPubMed
19.Basu, A, Manning, W, Mullahy, J. Comparing alternative models: log vs Cox proportional hazard? Health Econ 2004;13:749765.CrossRefGoogle ScholarPubMed
20.Schulgen, G, Kropec, A, Kappstein, I, Daschner, F, Schumacher, M. Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. J Clin Epidemiol 2000;53:409417.Google Scholar
21.Graves, N, Weinhold, D, Birrell, F, et al.The effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol 2007;28:280292.Google Scholar
22.Graves, N, Weinhold, D, Roberts, JAR. Correcting for bias when estimating the cost of hospital-acquired infection: an analysis of lower respiratory tract infections in nonsurgical patients. Health Econ 2005;14(7):755761.Google Scholar
23.Beyersmann, J, Wolkewitz, M, Schumacher, M. The impact of time-dependent bias in proportional hazards modelling. Stat Med 2008;27(30):64396454.Google Scholar
24.Rosenthal, V, Graves, N, Maki, D. An International Nosocomial Infection Control Consortium (INICC) goals and objectives, description of surveillance methods and operational activities. Am J Infect Control 2008;36(9): e1e12.CrossRefGoogle ScholarPubMed
25.Edwards, JR, Peterson, KD, Andrus, ML. National Healthcare Safety Network (NHSN) report, data summary for 2006, issued June 2007. Am ] Infect Control 2007;35:290301.Google Scholar
26.Putter, H, Fiocco, M, Geskus, RB. Tutorial in biostatistics: competing risks and multistate models. Stat Med 2007;26(11):23892430.Google Scholar
27.Dobson, AJ, Barnett, AG. An Introduction to Generalized Linear Models. Texts in Statistical Science. 3rd ed. Boca Raton, FL: Chapman & Hall/CRC, 2008.Google Scholar
28.Allignol, A. etm: Empirical Transition Matrix. Version 0.4-7. http://cran.r-project.org/web/packages/etm/etm.pdf. Published 2009. Accessed September 14, 2010.Google Scholar
29.Barnett, A, Batra, R, Graves, N, Edgeworth, J, Robotham, J, Cooper, B. Using a longitudinal model to estimate the effect of methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit. Am J Epidemiol 2009;170(9):11861194.Google Scholar
30.Plummer, M. JAGS, version 1.0.3 manual, http://sourceforge.net/projects/mcmc-jags/files/Manuals/2.0/jags_user_manual.pdf/download. Published September 9, 2008. Accessed September 14, 2010.Google Scholar
31.Plummer, M, Best, N, Cowles, K, Vines, K. coda: Output analysis and diagnostics for MCMC. In: 2009:R, version 0.13-4.Google Scholar
32.Beyersmann, J, Gastmeier, P, Wolkewitz, M, Schumacher, M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008;61:12161221.Google Scholar
33.Beyersmann, J, Kneib, T, Schumacher, M, Gastmeier, P. Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol 2009;30:273276.CrossRefGoogle ScholarPubMed
34.Kahn, JM, Rubenfeld, GD, Rohrbach, J, Fuchs, BD. Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients. Med Care 2008;46:12261233.CrossRefGoogle ScholarPubMed
35.Roberts, RR, Frutos, PW, Ciavarella, GC, et al.Distribution of fixed vs variable costs of hospital care. JAMA 1999;281(7):644649.CrossRefGoogle ScholarPubMed
36.Graves, N, Halton, K, Lairson, D. Economics and preventing hospital-acquired infection- broadening the perspective. Infect Control Hosp Epidemiol 2007;28(2):178184.CrossRefGoogle ScholarPubMed
37.Scott, RD, Soloman, SL, McGowan, JE. Applying economic principles to health care. Emerg Infect Dis 2001;7(2):282285.Google Scholar
38.Schoenfeld, DA, Richter, JR. Nomograms for calculating the number of patients needed for a clinical trial with survival as an end point. Biometrics 1982;38:163170.Google Scholar